Navigation Links
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome

NEW YORK, May 22, 2007 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. and Cypress Bioscience, Inc. today announced that preliminary top-line results from a 1,196 patient randomized, three month, double-blind, placebo-controlled pivotal Phase III study demonstrate statistically significant therapeutic effects of milnacipran as a treatment of fibromyalgia syndrome. At this time the companies have only been able to review initial top-line results and further analyses will be completed in the coming weeks to examine the results in greater detail.

Preliminary Study Results

In the study, patients were randomized to receive either 200mg per day of milnacipran (n=396), 100mg per day of milnacipran (n=399) or placebo (n=401). The primary pre-defined endpoints of this trial were composite responder assessments to evaluate either the treatment of the pain associated with fibromyalgia syndrome or the overall treatment of fibromyalgia syndrome. This composite responder analysis approach, which requires a clinically meaningful improvement in multiple domains, captures in one endpoint improvement in numerous symptoms which comprise this syndrome.

The treatment of pain associated with fibromyalgia is assessed by evaluating pain as measured by the Patient Experience Diary (PED), and the overall impression of patient well being as measured by the Patient Global Impression of Change (PGIC) for patients receiving either dose of milnacipran compared to placebo. The difference between active doses and placebo was assessed by a responder analysis with a responder defined as a subject experiencing both a 30% or greater reduction in pain compared to baseline as measured by a visual analog scale (VAS) and a self assessment of his or her condition by the patient of either "much" or "very much" improved compared to baseline.

The broader evaluation of treatment of fibromyalgia syndrome is assessed by evalua
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jq34zf/investigation ... Report on China,s Tobramycin Market, 2010-2019" report to ... whose eye drop and ointment are the most common ... inflammation caused by eye infection. Currently, dozens of enterprises ... produce tobramycin, among which the Top 5 are s.a. ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rktnl9/investigation ... "Investigation Report on China,s Insulin Aspart Market, 2010-2019" ... by Novo Nordisk, insulin aspart (under the trade ... the treatment of diabetes. Compared with human insulin, ... starts working fast and reports higher peak of ...
(Date:8/28/2015)... , Aug. 28, 2015  IP Shakti, LLC, today announced ... Logo - ... "Our new corporate identity signifies our transformation into a ... predictive analytics platform for patent claim validity." ... of the proprietary AIA Shield™ platform, the Company commenced a ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... CALGARY, June 20, 2007 /PRNewswire-FirstCall/ - SemBioSys,Genetics ... portfolio of,therapeutic proteins for metabolic and cardiovascular ... a scientific poster and,abstract at the 67th ... in Chicago. The Company's poster will disclose,recent ...
... Follow,Presentation, DANBURY, Conn., June 20, 2007 /PRNewswire-FirstCall/ -- ... of its,leading product candidate, VIAject(TM), at the 67th ... held in,Chicago, June 22 through June 26. , ... place on June 22,from 4:15 - 6:15pm CST, ...
Cached Medicine Technology:SemBioSys to present new data at American Diabetes Association,annual meeting 2SemBioSys to present new data at American Diabetes Association,annual meeting 3Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting 2Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting 3
(Date:8/30/2015)... Raton, Fl (PRWEB) , ... August 30, 2015 , ... ... to have beneficial effects as sleep aids and calming remedies, which help to improve ... the result of a great deal of research in the field of regenerative medicine ...
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... ... Kall has been promoted from Administrative assistant to Executive Assistant to CEO Mitch ... with a proven professional, focused on your goals. Kathleen graduated from Florida ...
(Date:8/29/2015)... ... ... On September 30, 2015, the Career and Transfer Center (CTC) at ... Community Colleges , will be hosting a Job Expo to provide a professional, open ... The Expo has expanded to much more than just a typical job and career ...
(Date:8/29/2015)... ... August 29, 2015 , ... "I have been a ... N.Y. "I specialize in manual therapy, and my invention will provide headache sufferers ... for additional muscle dysfunction throughout the body." , They developed THE RELIEVER to ...
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President ... to increase acceptance of the chiropractic field in the military. All too often VA ... Although Chiropractic was made available to the VA program over a decade ago, the ...
Breaking Medicine News(10 mins):Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2
... flush-and-forget-it indoor plumbing to be the pinnacle of ... far better solution for many parts of the ... , Associate Professor David Watkins, Professor James Mihelcic ... Sustainable Futures Institute analyzed worldwide barriers to sanitation. ...
... a safety hazard to the public, agency says , , TUESDAY, ... Administration has sent letters warning more than two dozen companies ... cure cancer. , The agency is also cautioning consumers not ... tonics, black salves, and creams, and are sold under various ...
... Synovics,Pharmaceuticals, Inc. (OTC Bulletin Board: SYVC), a ... Report,with the Securities and Exchange Commission. Consolidated gross ... 2008 were $6,121,632 compared,to $5,713,761 for the same ... strong growth of the over-the-counter (OTC) product line ...
... Parks Associates, leading analysts will,explore the implications of ... in homes as a kickoff to CONNECTIONS(TM): The,Digital ... Roundtable: Top Trends to Watch, Tuesday, June 24,will ... focus on trends in,broadband and access services, video ...
... is available in Spanish . , The use ... to regenerate the bone and hasten the integration between the ... reduce from six months to two weeks the wait time ... the oral implant., This advance has been the resulto f ...
... Show in New York City from June ... ... for those with food allergies, are lactose intolerant, vegetarians,vegans, celiacs and health ... an exciting variety of 59 types of sauces,that include stir-fry sauces, dipping ...
Cached Medicine News:Health News:FDA Warns Companies to Stop Selling Fake Cancer Cures 2Health News:FDA Warns Companies to Stop Selling Fake Cancer Cures 3Health News:Synovics Pharmaceuticals Files Its Second Quarter, 2008 Form 10Q with the SEC 2Health News:Synovics Pharmaceuticals Files Its Second Quarter, 2008 Form 10Q with the SEC 3Health News:Synovics Pharmaceuticals Files Its Second Quarter, 2008 Form 10Q with the SEC 4Health News:Synovics Pharmaceuticals Files Its Second Quarter, 2008 Form 10Q with the SEC 5Health News:Parks Associates Analysts Present Insights on Broadband, Digital Content, Advertising, Home Systems, and Digital Health at CONNECTIONS(TM) 2Health News:Scientists from Granada drastically reduce the wait time for new teeth implant 2Health News:WORLDFOODS Provides All Natural Authentic Asian Sauces That Cater to Vegetarians, Celiacs and Those With Food Allergies 2
Blood pressure monitor will measure blood pressures and pulse rates accurately and reliably....
... Blood Glucose Monitoring System has the largest ... really easy to see and hold. FreeStyle ... the smallest sample of blood. And it's ... 5 seconds. With 4 programmable alarms, you'll ...
When you use the optional REAL-Time Continuous Glucose Monitoring Kit with your insulin pump, you will have access to REAL-Time glucose readings, safety alarms, and glucose trend data around the cloc...
... into testing wells and read results. ... multiple drug screen cassette that can ... adulterants. It can test from one ... can be accompanied with four (4) ...
Medicine Products: